Acorda Therapeutics Inc. shares rallied in the extended session Monday after the U.S. Patent and Trademark Office denied a patent challenge against the company. Acorda shares jumped 24% to $36. The patent office on Monday denied a petition from the Coalition For Affordable Drugs challenging the patentability of Acorda’s multiple sclerosis drug Ampyra.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News